Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1752 |
GP(33-41)
|
||
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Db molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM. GP33-41 Epitopeis a strong agonist of CD8 T cells | |||
TP1758L |
LCMV gp33-41 acetate
LCMV gp33-41 acetate(151705-84-9 Free base) |
Others | Others |
LCMV gp33-41 acetate 是淋巴细胞性脉络丛脑膜炎病毒的序列,受主要组织相容性复合体 I 类 H-2Db 限制,呈递给细胞毒性 T 淋巴细胞。 | |||
TP1758 |
LCMV gp33-41
|
||
LCMV gp33-41, the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes.This is the H-2Db restricted epitope derived from the lymphocytic | |||
T75766 |
GP(33-41) TFA
|
||
GP(33-41) TFA 是一种由 9 个氨基酸残基组成的多肽,它是淋巴细胞性脉络丛脑膜炎病毒 GP1 抗原决定基中的序列。GP(33-41) TFA 能够上调 RMA-S (Db Kb) 细胞表面 H-2Db 分子,SC50值为 344 nM。 | |||
T75982 |
LCMV gp33-41 TFA
|
||
LCMV gp33-41 (TFA)是一种带有羧基延伸的11-aa长肽,作为淋巴细胞脉络丛脑膜炎病毒序列,在MHC I类H-2Db分子的限制下,能够被呈递给细胞毒性T淋巴细胞。 | |||
TP1629 |
LCMV gp33-41 (TFA) (151705-84-9 free base)
LCMV gp33-41 (TFA) |
||
LCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes[1]. |